Evidence for consistency of the glycation gap in diabetes

Diabetes Care

Volumn 34, Issue 8, 2011, Pages 1712-1716

  Nayak, Ananth U ^a   Holland, Martin R ^a   MacDonald, David R ^a   Nevill, Alan ^b   Singh, Baldev M ^a  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EXPERIMENTAL DESIGN; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLYCATION GAP; GLYCEMIC CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OUTCOME ASSESSMENT; PREDICTION; REFERENCE VALUE; SCORING SYSTEM; STANDARDIZATION; ADOLESCENT; BLOOD; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84856020837     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1767     Document Type: Article

References (21)

1. 1c as assessed by simultaneously measuring fructosamine and use of error grid analysis. Ann Clin Biochem 2008;45: 421-425
2. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002; 16:313-320
3. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 1990;33:208-215 (Pubitemid 20136237)
4. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 2004;21:657-665 (Pubitemid 38916208)
5. Kilpatrick ES. Problems in the assessment of glycaemic control in diabetes mellitus. Diabet Med 1997;14:819-831 (Pubitemid 27448930)
6. 1c. Blood 2008;112:4284-4291
7. Khera PK, Joiner CH, Carruthers A, et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 2008;57:2445-2452
8. Delpierrre G, Vertommen D, Communi D, Rider MH, Van Schaftingen E. Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin. J Biol Chem 2004;279:27613-27620 (Pubitemid 38812603)
9. Delpierre G, Veiga-da-Cunha M, Vertommen D, Buysschaert M, Van Schaftingen E. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. Diabetes Metab 2006;32: 31-39 (Pubitemid 43872593)
10. 1cLevels and the onset of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2010;118:209-212
11. Gould BJ, Davie SJ, Yudkin JS. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 1997;260:49-64 (Pubitemid 27136412)
12. 1cand fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26: 163-167
13. Dominiczak MH, Orrell JM, Finlay WEI. The effect of hypoalbuminaemia, hyper-bilirubinaemia and renal failure on serum fructosamine concentration in non-diabetic individuals. Clin Chim Acta 1989;182: 123-129
14. Ardawi MSM, Nasrat HAN, Bahnassy AA. Fructosamine in obese normal subjects and type 2 diabetes. Diabet Med 1994;11: 50-56 (Pubitemid 24040542)
15. McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004; 27:1259-1264 (Pubitemid 38679967)
16. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318: 1315-1321
17. Goh SY, Cooper ME. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93: 1143-1152 (Pubitemid 351519698)
18. Cohen RM, Snieder H, Lindsell CJ, et al. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care 2006;29:1739-1743 (Pubitemid 44156623)
19. Soranzo N, Sanna S, Wheeler E, et al.; WTCCC. Common variants at 10 genomic loci influence hemoglobin A1(C) levels via glycemic and nonglycemic pathways. Diabetes 2010;59:3229-3239
20. 1c in evaluating the achievement of therapeutic goals in diabetes? Diabetes Metab 2001;27:598-603
21. Chalew SA, McCarter RJ, Thomas J, Thomson JL, Hempe JM. A comparison of the Glycosylation Gap and Haemoglobin Glycation Index in patients with diabetes. J Diabetes Complications 2005;19:218-222 (Pubitemid 40910203)